Animals and reproductive management
All experimental procedures were performed according to Austrian animal welfare legislation and approved by the Austrian Federal Ministry for Science and Research (license number BMWFW-68.205/0135-WF/V/3b/2014). Fifteen healthy and fertile Haflinger mares (4–16 years old) were used as embryo donors. Animals were kept in a large paddock with access to a shed, fed with hay and mineral supplements twice daily, and water was available ad libitum. The ovaries and uterus of mares were scanned transrectally with an ultrasound machine (Mindray M9, Mindray, Shenzhen, China) equipped with 5–8 MHz linear-array transducer (6LE5Vs) to detect a 3.5 cm preovulatory follicle and uterine oedema characterizing estrous and determinate the time for artificial insemination [26]. Insemination was performed with either raw or extended (Equi Pro, Minitube, Tiefenbach, Germany) semen. One insemination dose contained at least 500 million progressively motile spermatozoa. Semen was collected from fertile stallions by artificial vagina using routine procedures [27]. The mares were inseminated at intervals of 48 h and checked every 24 h until ovulation was detected. No hormonal treatments were administered during the experimental period.
Experimental design
Equine embryos (n = 80) were collected on day 7 (n = 60) or day 8 (n = 20) after ovulation and assigned to 4 groups with 20 embryos per group: (i) day 7 control (E7F, fresh); (ii) day 7, 24 h at 5 °C (E5C); (iii) day 7, 24 h at 20 °C (E20C); (iv) day 8 control (E8F). For short-term storage, embryos were kept in holding medium (Minitube) within an Equitainer (Hamilton Biovet, Ipswich, MA, USA). The embryos and medium from all treatments were submitted to the following assessments: temperature, pH, lipid peroxidation, embryo morphology, mRNA expression, and DNA methylation (immunohistochemistry and gene-specific DNA methylation).
Collection and evaluation of embryos
Embryos were recovered on days 7 and 8 after ovulation (day 0, ovulation detection) using an intrauterine silicone 2-way Foley catheter CH 28 for mares (Minitube). The uterus was washed four times with 1 L of Ringer’s lactate solution (Fresenius Kabi, Graz, Austria) prewarmed at 38 °C. The fluid recovered from the uterus was filtered through an embryo filter system (75 µm, EmCon embryo filter; Immunosystems, Spring Valley, WI, USA). The solution remaining in the filter cup was placed in a petri dish and analyzed under a stereomicroscope at 40 × magnification. Embryos were washed 10 times in holding medium (Minitube) to remove cellular debris. Embryos were measured with a microscopic scale and morphologically classified according to their quality on a scale from 1 (excellent) to 4 (degenerated) as described [28].
Holding medium temperature and pH
The temperature of the holding medium was recorded with a data logger (testo 175, Testo, West Chester, PA, USA) every 10 min for 24 h. Briefly, a second tube with the same volume of holding medium as for the embryo was placed inside the Equitainer and the fine sensor of the data logger was placed inside this holding medium for temperature monitoring.
The pH was assessed in a sample of the holding medium immediately before and after embryo storage for 24 h. The pH was assessed by a pH meter (SevenCompact S220-micro-kit, Mettler Toledo, Columbus, OH, USA) using the microelectrode (InLab Ultra-Micro-ISM, Mettler Toledo) for small sample volumes.
Lipid peroxidation
Lipid peroxidation was determined by the reaction of malondialdehyde (MDA) with thiobarbituric acid (TBA) to form a fluorometric (λex = 532/λem = 553 nm) product, proportional to the MDA present, using a commercial kit (Cat#MAK085, Sigma-Aldrich Co., St. Louis, MO, USA) and following the principles and methods previously described [29]. Briefly, the MDA standards were prepared by dilution of 10 µL of the 4.17 M MDA standard solution with 407 µL of water to prepare a 0.1 M MDA standard solution. Further, 20 µL of the 0.1 M MDA standard solution was diluted with 980 µL of water to prepare a 2 mM MDA standard to generate 0 (blank), 0.4, 0.8, 1.2, 1.6, and 2.0 nanomole standards. Later, a sample (20 µL) of the spent holding medium was gently mixed with 500 µL of 42 mM sulfuric acid in a microcentrifuge tube. Phosphotungstic acid solution (125 µL) was added to the samples, mixed by vortex, incubated at room temperature for 5 min, and then centrifuged at 13,000 × g for 3 minutes. The pellet was resuspended on ice with the 100 µL water/BHT solution (2%) and adjusted to a volume of 200 µL with water. The assay reaction was performed following the manufacturer instructions using a fluorometer (Victor 2D, Perkin Elmer, Santa Clara, CA, USA) and the data were analyzed by the software SoftMax Pro 6.5.1. (Molecular Devices, LLC, Sunnyvale, CA, USA). All samples and standards were run in duplicate.
Quantitative real-time PCR
Embryos from all groups (n = 24, 6 per group) were placed in 350 µl RLT buffer (Qiagen, Hilden, Germany) and stored at -80 °C. For RNA extraction from single embryos, 3.5 µl 2-mercapoethanol (Sigma-Aldrich) were added to the solution and RNA extraction and DNase I digestion were performed with the RNeasy Micro Kit (Qiagen) according to the recommended protocol for animal and human tissues. For qPCR, 6 µl of total RNA were transcribed into cDNA using the SuperScript III First-Strand Synthesis system with random hexamer primers (Invitrogen, Carlsbad, CA, USA) in accordance with the manufacturer’s instructions. Two replicates per sample were reserve transcribed and pooled for qPCR. Primer and hydrolysis probes for the equine target genes ATP1A1, BAX, BCL2, CYP19A1, DNMT1, DNMT3A, DNMT3B, DNMT3L, ESR1, H19, IGF1, IGF2, NANOG, POU5F1, PTGES2, and SOX2, were designed using the PrimerQuest assay tool (https://eu.idtdna.com/PrimerQuest/Home/Index; Integrated DNA Technologies, Coralville, IA, USA) or taken from the literature [30–33]. Two reference genes (RG), PSMB4 and SNRPD3, were included for normalization [34]. Assay details and full names of the genes investigated are listed in Table 1. All hydrolysis probes were dual-labelled with 6-carboxyfluorescein (FAM) on the 5’ end and Black Hole Quencher 1 (BHQ1) on the 3’ end. The assays were validated by generation of standard curves to determine PCR reaction efficiencies using the formula E = 10− 1/slope – 1 [35]. Efficiency-corrected Cq values were used for analysis. Real-time PCR quantification of the target genes using hydrolysis probes was performed as described [33]. The RG were measured with the fluorescent DNA dye SYBR Green. Reaction conditions have been described [34]. Target gene expression levels were normalized to the geometric mean of PSMB4 and SNRPD3 and relative expression changes were calculated with the comparative 2−ΔΔCT method [36].
Table 1
Primer for quantitative PCR.
Gene symbol | Gene name | NCBI/Ensemble accession number | Oligo sequence (5‘ − 3‘) | Amplicon length (bp) | PCR efficiency (%) | R2 value | Reference |
ATP1A1 | Equus caballus ATPase Na+/K + transporting subunit alpha 1 | NM_001114532.2, XM_023640223.1, XM_023640224.1 | F: CTTGATGAACTTCAGCGCAAATA R: GGTGTAAGGGCATTGGGA P: TGAGCCGAGGCTTAACAACTGCTC | 104 | 94 | 0.990 | This study |
BAX | Equus caballus BCL2-associated X protein | XM_014729721.1 XM_014729717.1 | F: AGGATGCGTCCACCAAGAAG R: CCTCTGCAGCTCCATGTTACTG P: CTCAAGCGCATCGGAGATGAGCTG | 80 | 93.2 | 0.994 | [33] |
BCL2 | Equus caballus B-cell lymphoma 2 | XM_001490436.2 | F: TTGGAAAGCCTACCACTAATTGC R: CCGTGTTTATAGGCACAGGAGAT P: CCCACCTGAGCGGCTCCACC | 74 | 92.6 | 0.998 | [33] |
CYP19A1 | Equus caballus cytochrome P450 family 19 subfamily A member 1 | NM_001081805.2 XM_005602588.2 XM_005602587.2 | F: GGAGAGGAAACGCTCGTTATTA R: CCCATATACTGCAACCCAAATG P: ATCACTACTCCTCCCGATTTGGCA | 107 | 99.2 | 0.999 | This study |
DNMT1 | Equus caballus DNA methyltransferase 1 | XM_014741825.1 | F: GACCACCATCACGTCTCATTT R: CTCCTCATCCACAGAATTGTCC P: AAACGGAAACCCGAGGAAGAGCTG | 97 | 100.5 | 1 | This study |
DNMT3A | Equus caballus DNA methyltransferase 3 alpha | XM_005600169.2 XM_005600168.2 XM_005600167.2 XM_005600170.2 XM_005600171.2 | F: GATTATTGACGAACGCACAAGAG R: GTGTTCCAGGGTGACATTGA P: TGCAAATGTCTTCGATGTTCCGGC | 112 | 100 | 0.998 | This study |
DNMT3B | Equus caballus DNA methyltransferase 3 beta | XM_001916514.4 | F: CGAGTCTTGTCCCTGTTTGAT R: GCGATAGACTCTTCACACACTT P: CGCCACAGGGTACTTGGTTCTCAA | 110 | 100.6 | 0.999 | This study |
DNMT3L | Equus caballus DNA (cytosine-5-)-methyltransferase 3-like | XM_014736476.1 | F: GCCCTCACTTGGTTGGTTT R: CTTCCACACAGGCACAGTTT P: CAAAGTGCCCATCTGCTCTGGAGA | 98 | 100.5 | 0.999 | This study |
ESR1 | Equus caballus estrogen receptor 1 | NM_001081772.1 | F: CACCCAGGAAAGCTCCTATTT R: CGAGATGACGTAGCCAACAA P: TCCACCATGCCCTCTACACATTTCC | 110 | 101.8 | 0.999 | This study |
H19 | Equus caballus H19, imprinted maternally expressed transcript | NR_027326.2 | F: CCTCTAGCTCTGACTCAAGAATATG R: CAGGTCCATCTGGTTCCTTTAG P: ACTCAGGAATCAGCTCTGGAAGGT | 103 | 94.3 | 0.992 | This study |
IGF1 | Equus caballus insulin like growth factor 1 | NM_001082498.2 XM_005606471.2 XM_005606472.2 XM_005606470.2 XM_005606469.2 | F: TGCTTCCGGAGCTGTGATCT R: CCGACTTGGCAGGCTTGA P: AGGAGGCTGGAGATGTACTGCGCACC | 67 | 102 | 1 | [30] |
IGF2 | Equus caballus insulin like growth factor 2 | NM_001114539.2 | F: AAGTCCGAGAGGGACGTG R: ATTGCTTCCAGGCGTTGT P: CCCGTGGTCAAGCTCTTCCAGT | 100 | 99.9 | 0.998 | This study |
NANOG | Equus caballus Nanog homeobox | XM_014740545.1 XM_001498808.1 | F: ACAGCCCCGATTCATCCA R: TCTTTGCCTCGCTCGTCTCT P: CAGTCCCAGAGTAAAACCGCTGCCC | 72 | 102.3 | 0.999 | [31] |
POU5F1 | Equus caballus POU class 5 homeobox 1 | XM_014734675.1 XM_001490108.5 | F: CGGGCACTGCAGGAACAT R: CCGAAAGAGAAAGCGAACTAGTATTG P: TTCTCCAGGTTGCCTCTCACTCGGTTC | 73 | 100.8 | 0.999 | [31] |
PSMB4 | Equus caballus proteasome subunit beta type IV | XM_001492317.4 XM_005610132.1 XM_008515015.1 XM_005613704.1 | F: CTTGGTGTAGCCTATGAAGCCC R: CCAGAATTTCTCGCAGCAGAG | 82 | 93.1 | 0.991 | [34] |
PTGES2 | Equus caballus prostaglandin-endoperoxide synthase 2 | NM_001081775.2 | F: GAGGTGTATCCGCCCACAGT R: AGCAAACCGCAGGTGCTC P: TCAGATGGAAATGATCTACCCGCCTCA | 81 | 92.3 | 0.996 | [32] |
SNRPD3 | Equus caballus small nuclear ribonucleoprotein D3 polypeptide. | XM_001489060.4 XM_008511652.1 | F: ACGCACCTATGTTAAAGAGCATG R: CACGTCCCATTCCACGTC | 120 | 99.4 | 0.996 | [34] |
SOX2 | Equus caballus SRY box 2 | XM_003363345.3 | F: TGCGAGCGCTGCACAT R: AGCGTGTACTTATCCTTCTTCATGAG P: ATAAATACCGTCCTCGGCGGAAAACCAA | 91 | 99.3 | 0.998 | [31] |
R2: correlation coefficient of standard curve; F and R: forward and reverse primer; P: hydrolysis probe |
Gene-specific DNA methylation analysis
The analysis of gene-specific DNA methylation was based on a protocol previously implemented for bovine oocytes [37]. Briefly, DNA from single equine embryos (n = 28; n = 7 per group) was isolated and bisulfite-treated with the EZ DNA Methylation Direct Kit (Zymo Research, Irvine, CA, USA) following the recommended protocol for samples containing up to 2 × 103 cells. Bisulfite-converted DNA was eluted with 10 µl M-Elution Buffer (Zymo Research) into 1.5 ml DNA LoBind tubes (Eppendorf, Hamburg, Germany). Selection of target regions for bisulfite sequencing and primer design was done with the MethPrimer online tool [38]. The genomic sequences 2,000 bp upstream of the transcription start sites of the equine genes, CYP19A1, DNMT1, DNMT3A, DNMT3B, ESR1, NANOG, PTGES2 and SOX2, were screened for CpG islands or CG-rich regions using the CpG island prediction function of the MethPrimer tool. For multiplex nested PCR, two sets of primers, an outer primer for a first-round multiplex PCR amplification of all 8 genes and an inner primer for a second gene-specific single nested PCR, were designed for each gene (Table 2). Primers were designed to bind outside the CG-rich areas and to amplify as many CpG dinucleotides as possible. Due to missing sequence data in the horse genome (EquCab2) upstream of the PTGES2 gene, only one primer set could be designed for PTGES2 which was used in both PCR reactions. The multiplex PCR was performed in 25 µl reaction volumes including 200 µM of each dNTP, 1 x buffer B2 (Solis BioDyne, Tartu, Estonia), 3 mM MgCl2, 120 nM of each outer primer, 1.2 units HOT FIREPol DNA polymerase (Solis BioDyne) and 2 µl bisufite-treated DNA. The PCR reaction was carried out using the following temperatures: initial denaturation at 95 °C for 10 min, followed by 34 cycles of 95 °C for 30 sec, 54 °C for 30 sec, and 72 °C for 1 min, and a final elongation step at 72 °C for 7 min. One µl of the multiplex PCR product was used as template for the subsequent nested PCR, performed in 25-µl reaction volumes using the same mastermix components as described for the multiplex PCR except that the outer primer-mix was replaced with 500 nM of each gene-specific inner forward and reverse primer. The temperature protocol for multiplex PCR was also applied for the nested PCR, only the annealing temperature and cycle number were adjusted for each gene (CYP19A1: 56 °C, 35 cycles; DNMT1 and DNMT3A: 59 °C, 35 cycles; DNMT3B, ESR1 and NANOG: 60 °C, 35 cycles; PTGES2: 56 °C, 40 cycles; SOX2: 58 °C, 40 cycles). Aliquots of the PCR products were run in a 2% agarose gel to confirm the correct size of the amplicons. The remaining aliquots were used for direct Sanger sequencing performed by Microsynth, Vienna, Austria. To improve the quality of the sequencing data, the amplicons of ESR1 and PTGES2 were isolated from the 2% agarose gel and purified using the Zymoclean Gel DNA Recovery kit (Zymo Research) prior to sequencing. Data analysis was performed with CLC Genomics Workbench 9 software (Qiagen). The sequence electropherograms were investigated for methylated “C” and unmethylated “T” peaks within a CpG context. CpGs with a “C” signal > 80% were categorized as methylated, whereas methylation values < 20% were categorized as unmethylated. Methylation values between 20 and 80% were designated as an unclear methylation status [37].
Table 2
Multiplex nested PCR primer for DNA methylation analysis.
Gene | Primer Sequence (5’ – 3’) | Amplicon length (bp) | Genomic localization (EquCab2) | Number of CpGs in inner amplicon | Number of sequenced CpGs |
CYP19A1 | Outer forward: TTTTAGTTTTGATTGGTTGTTTTT Outer reverse: CTAAACCCCATAAAACATCTCTTAC | 317 | 1:139092647–139092963 | - | - |
Inner forward: TTTTTTTTGTAAGATTAGTGAGTATATTTA Inner reverse: TTTCCAAAATTAAAAAACATAACC | 212 | 1:139092716–139092927 | 4 | 3 |
DNMT1 | Outer forward: AATTTTTTTTAAGAGTTTGGTATGG Outer reverse: ACCAATCCTCCTCTTTATACTAAAA | 264 | 7:49740491–49740754 | - | - |
Inner forward: GAGTTTGGTATGGTATATAAGTGTTGA Inner reverse: AAAAAACTAACCCTAAACTCACATC | 229 | 7:49740503–49740731 | 9 | 8 |
DNMT3A | Outer forward: GGGATTGATTAGATTTTTTAGAGAAG Outer reverse: TAATAACACTAAATCCCTCCAAAAC | 316 | 15:70660175–70660490 | - | - |
Inner forward: TAGGAGTTTAGTGGGGGAATAGT Inner Reverse: ATAAAATAAATAAAACCCCTACACC | 200 | 15:70660225–70660424 | 6 | 4 |
DNMT3B | Outer forward: TTAAAGGGGGAATAGTAGAAGTTTA Outer reverse: CAACTCCAAAAATATTTAAAATCAC | 388 | 22:23584114–23584353 | - | - |
Inner forward: TATAGAGGATGGATTTGGGATTTTA Inner reverse: ACTAAACACTCCCTACCCTAATACC | 240 | 22:23584114–23584353 | 10 | 8 |
ESR1 | Outer forward: TTGTGGTAGGTATGAATATTTATGTG Outer reverse: ATTACATATACAACCAACCACAAAC | 334 | 31:15330033–15330366 | - | - |
Inner forward: AATTTTTAGTGGGAGGAAGTATAGTAT Inner reverse: ACATAAACTAACAAAAAACATCCC | 226 | 31:15330075–15330300 | 9 | 8 |
NANOG | Outer forward: TGGAAATATGGTGAATTTATAGGTAT Outer reverse: AACTTAAATATCCAAACAAAAAACC | 387 | 6:35487982–35488368 | - | - |
Inner forward: TTGGTAGATAGGATTAATTGAGAATT Inner reverse: CAAACAAAAAACCTTAAAAAAATAC | 237 | 6:35487994–35488230 | 8 | 7 |
PTGES2 | Forward: GATTTATTTAAGAGTGGGGGAGGT Reverse: CAATATAAAACCCCAACC | 205 | 25:31473304–31473508 | 17 | 11 |
SOX2 | Outer forward: ATTTTTAATATAGAATAAATTATGGAGAAG Outer reverse: AAATAAAAATAAAACAAAACAAAATAAATA | 302 | 19:20356881–20357182 | - | - |
Inner forward: ATAGAATAAATTATGGAGAAGTAAGGAG Inner reverse: CTATCCTACTAAAATTTCAAAAACC | 253 | 19:20356889–20357141 | 19 | 13 |
Global methylation - immunofluorescence staining for 5mC and 5hmC
Embryos (n = 28; n = 7 per group) from all treatment groups were prepared for immunofluorescence staining as previously described [39, 40] with minor modifications. Briefly, embryos were removed from the holding medium, washed in PBS, and fixed in ice-cold 4% paraformaldehyde (PFA; Sigma-Aldrich) for 25 min at room temperature (RT). Embryos were washed in PBS and kept for 25 min at RT in PBT (0.05% Tween-20 in PBS), permeabilized in 0.2% triton X-100 solution for 40 min at RT, washed 3 times and stored in 100 µL of PBT at 4 °C for the antibody staining. Embryos were depurinated in 4N HCl 0.1% Triton X-100 for 20 min at RT, washed in PBS and kept in PBT for 30 min at RT, and incubated in blocking solution (2% BSA in PBT) overnight at 4 °C. Later, embryos were incubated with the primary antibody (5mC mouse monoclonal antibody, EpiGentek, Farmingdale, NY, USA; or 5hmC mouse monoclonal antibody, Active Motif, Carlsbad, Ca, USA) at 1:200 in blocking solution for 1 h at RT, washed in PBT and incubated with Alexa Fluor 594 goat anti-mouse IgG (Thermo, Waltham, MA, USA) for 1 h in blocking solution at RT in the dark. Finally, embryos were washed in PBT, incubated in DAPI solution for 10 min at RT, then washed in PBT and prepared in a chamber for confocal microscopy (LSM 880, Carl Zeiss, Oberkochen, Germany). Scanning was conducted with Z stack of 25 optical series from the bottom to the top of the embryos with a step size of 65 µm to allow three-dimensional distribution analysis. Images were obtained at 20 × objective magnification and analysed using ImageJ software (version 1.50f).
Statistical analysis
The software SPSS version 24 (IBM-SPSS, Armonck, NY, USA) was used for statistical analyses. Data were tested for normal distribution by Kolmogorov-Smirnov test. Because embryo size was not normally distributed (P < 0.05), comparison of embryo size among groups was made with non-parametrical tests (Mann-Whitney test for fresh embryos collected on days 7 and 8, Wilcoxon test for the comparison of embryo size before and after storage in groups E5C and E20C, respectively). For the analysis of pH, lipid peroxidation, gene expression, and DNA methylation, one-way ANOVA with subsequent Tukey test were used to analyze differences among groups. Data are shown as mean ± standard error of the mean (SEM). A P value < 0.05 was considered statistically significant.